Article
NFIB promotes cell survival by directly suppressing p21 transcription in TP53‐mutated triple‐negative breast cancer
23 Oct 2018
Abstract excerpt
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited treatment options and poor prognosis. There is an urgent need to identify and understand the key factors and signalling pathways driving TNBC tumour progression, relapse, and treatment resistance. In this study, we report that gene copy numbers and expression levels of nuclear factor IB (NFIB), a recently identified oncogene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
